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SUMMARY 
Background: Since the 1930s, the Department of Psychiatry and Psychotherapy at Semmelweis University (DPPSU) in Budapest 
has played a leading role in convulsive therapy in Hungary. The aim of this study was to describe the pattern of ECT use at the 
DPPSU over an 11-year period.  
Subjects and methods: Analysis of the medical notes of all patients treated with ECT in this academic centre between 1999 and 
2009. 
Results: During the study period, 28,230 patients were admitted to the DPPSU, of whom 457 (1.6%) received ECT. More than 
50% of patients receiving ECT were diagnosed with schizophrenia. The percentage of female patients receiving ECT significantly 
exceeded that of the male patients, above what was expected in view of the diagnostic mix.  
Conclusion: The data indicate that in the first decade of the 21th century, ECT use shows a declining tendency in this Hungarian 
academic centre. The mean number of treatment sessions was relatively low and nearly the same across diagnostic groups. ECT was 
mainly used as a last resort for treatment-resistant patients. In the majority of cases, bifronto-temporal brief pulse stimulation was 
applied. Seizures were monitored with EEG and EMG. 
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INTRODUCTION 
From the very beginning of its introduction to 
psychiatry, the Department of Psychiatry and Psycho-
therapy at Semmelweis University (DPPSU) has played 
a pioneering role in using and promoting convulsive 
therapy in Hungary. László Meduna conducted his 
neuropathological studies comparing the brains of 
patients suffering from epilepsy or schizophrenia while 
working at this Department, in an attempt to establish 
the theoretical basis of convulsive therapy. The 
Department was probably also the place where Meduna 
carried out his animal experiments to find the right 
chemical substance for seizure induction (Meduna 
1985). However, the first human convulsive treatment 
took place in the Royal National Hungarian Institute of 
Psychiatry and Neurology (Gazdag et al. 2007a), 
because Károly Schaffer, then the head of DPPSU did 
not approve the direction of Meduna’s research (Baran 
et al. 2008). Nevertheless, the DPPSU continued to play 
a defining role in the use of convulsive therapy in 
Hungary. Gyula Nyírő, the head of the Department in 
the 1960s, was the propagator of the regressive method 
of electroconvulsive therapy (ECT) in Hungary (Gazdag 
et al. 2007b). Among those who first applied ECT under 
general anaesthesia in Hungary were István Magyar and 
László Tringer who both became later professors in the 
Department (personal communication with László 
Tringer, 12/11/2012). The DPPSU carried out the 
highest number of ECT treatments in Hungary, with 2.6 
percent of the inpatients receiving ECT in 2002 (Gazdag 
et al. 2004a).  
Over the past decade, there has been a hetero-
geneous pattern of ECT use around the world. In some 
countries, the method has experienced a renaissance 
(Mugisha & Ovuga 1991, Selis et al. 2008, Minhas & 
Ostroff 2012, Loh et al. 2012, van Waarde et al. 2009), 
while in others its use has decreased significantly 
(Leiknes et al. 2012, Plakiotis & O'Connor 2012) or it 
has been banned (Gazdag et al. 2012). 
The aim of this survey was to describe the practice 
of ECT at DPPSU over an 11-year period to establish 
recent trends in ECT use in a centre of excellence in 
Central-Eastern Europe.  
 
SUBJECTS AND METHODS  
The medical files of the patients treated with ECT at 
the DPPSU between 1999 and 2009 were analyzed. 
During that period, at least one of two authors (GG, 
IZS) actively participated in performing ECT and thus 
guaranteed the quality of the data collection. The infor-
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mation extracted from the files included demographic 
and illness-related data and the following information 
on ECT: date of ECT, number of treatment sessions, 
number of repeated stimulations, stimulus intensity, 
EEG, EMG, seizure duration, dose of anaesthetics, 
blood pressure, heart rate and adverse effects.  
 
Statistical Analysis 
Statistical analysis was performed using SPSS, 
Version 11.5 (Chicago, IL, USA). Descriptive data are 
given with means and standard deviations. Diagnostic 
groups were compared with t-test and chi-square test, 
as appropriate. The annual variations of the number of 
patients treated with ECT were examined with the 
“curve estimation” method (Saha-Chaudhuri & 
Heagerty 2012). 
 
RESULTS  
ECT was performed with a Thymatron DGx machi-
ne (delivering constant-current, brief-pulse, bi-directio-
nal square-wave impulses). After premedication with 
atropine (0.5mg iv.), propofol (1 mg/kg) or etomidate 
(0.1mg/kg) was administered as an anaesthetic together 
with succinylcholine (50 mg) for muscle relaxation. 
Convulsions were monitored using the cuff method 
(Fink, 1994) coupled with EEG and EMG. Diagnoses 
were made according to ICD-10 criteria (World Health 
Organization 2010) by the patients’ attending psychia-
trists. 
During the 11-year period, the total in-patient 
turnover was 28,230 patients, 457 (1.61%) of whom 
received ECT. Thirty-six patients (7.9%) required a 
second course in the same year and in 3 cases (0.65%) 
three ECT courses were necessary in the same year. 
Altogether 233 (7.9%) repeated stimulations of the total 
of 2,940 stimulations were required because of ineffec-
tive first stimulations. Bifronto-temporal electrode 
placement was applied in all cases. The age method was 
employed to determine the initial stimulus intensity in a 
majority of the cases, except when dose titration was 
applied in the context of studies (Gazdag et al. 2004c, 
Iványi et al. 2007). Brief pulse stimulation was used in 
all cases. As the DPPSU lacked a proper ECT-suite, 
ECT was administered in general treatment rooms and 
the ward corridor was used for recovery.  
In Hungary, ECT can only be administered under 
anesthesia and muscle relaxation, and the assistance of 
an anesthesiologist has been mandatory since 1994 
(Welfare Ministry Order 1994). Contracting an 
anesthesiologist incurred significant costs for the 
institution.  
The characteristics of the ECT are shown by year in 
Table 1. Table 2 displays the characteristics of ECT in 
different diagnostic groups. There was no significant 
difference in the number of patients treated per year 
(p=0.08). The variation in the number of ECT is shown 
in Figure 1. The following adverse effects, all only mild 
and transient, were recorded: confusion (1.3%), sinus 
tachycardia (3.1%), psychomotor agitation (1.7%), 
hypertension (blood pressure above 140/90 Hgmm (Kim 
et al. 2013) 6.6%), nausea (0.2%), headache (1.5%), 
myalgia (0.7%), prolonged seizures (seizures lasting 
longer than 180 seconds (APA 2001; 0.4%), and 
sialorrhea (0.4). 
 
 
Figure 1. Number of ECT courses between 1999 and 
2009 
 
Table 1. Characteristics of ECT courses between 1999 and 2009  
Diagnosis (%)  Number  of patients 
Sex  
(male %) 
Age  
(mean) Schizophrenia Affective disorder
Stimulation  
energy 
Number of 
sessions 
1999 43 55.8 41.2±16.0 67.4 32.6 251.3±96.9 4.14±1.85 
2000 41 43.9 40.8±17.0 70.7 29.3 272.0±102.0 4.39±1.98 
2001 47 38.3 44.3±18.3 63.8 36.2 221.6±109.1 3.79±1.86 
2002 55 36.8 43.5±15.7 54.5 45.5 198.4±89.2 4.63±1.84 
2003 44 27.3 46.8±15.9 50.0 50.0 183.6±97.02 5.34±2.09 
2004 47 42.6 44.0±16.4 55.3 44.7 151.0±60.81 5.19±2.43 
2005 34 44.1 46.1±14.8 58.8 41.2 140.8±55.68 4.94±3.08 
2006 33 39.4 47.0±17.3 78.8 21.2 159.5±48.79 4.18±1.89 
2007 47 42.6 46.6±18.1 68.1 31.9 163.2±62.84 4.53±2.66 
2008 39 33.3 45.8±17.8 66.7 33.3 164.6±61.81 4.44±1.81 
2009 26 30.8 48.5±19.2 65.4 34.6 167.04±65.3 4.73±2.05 
Total      457 39.6 44.8±16.9 63.0 37.0 190.85±90.5 4.75±2.19 
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Table 2. Characteristics of ECT according to diagnostic groups  
 Schizophrenia Affective disorder Statistics 
Number of patients (%) 288 (63%) 169 (37%)  
Sex (percent of males) 44.7% 30.7%  
Age 38.9±15.10 54.8±15.04 t=10.8, p<0.01 
Stimulation energy 179.1±85.4 210.7±95.5 t=3.65, p<0.01 
Number of restimulations 1.89±1.13 2.14±1.41 p=0.251 
Number of sessions 4.63±2.25 4.49±2.10 t=3.65, p=0.42 
 
DISCUSSION 
With the development of psychopharmacology from 
the 1950s, the use of ECT has been declining 
significantly in Hungary, as it has been in most parts of 
the world (Gazdag et al. 2004a, McCall 2001, Gazdag et 
al. 2009a, Sienaert et al. 2006). In Australia the use of 
ECT began declining from 2001, with a little increase in 
2007 (Plakiotis et al. 2012). In the United Kingdom, a 
fall in the number of ECT was observed during the 
period of 2005-2006 (Scott 2012). The same decline in 
the administration of ECT in the past few years was 
reported from the United States (Case et al. 2013). In 
India, the percentage of ECT use remained constantly 
high over the past years, similar to the rest of Asia 
(Ganghadar et al. 2010, Little 2003). However, the 
descending trend is far from universal: ECT is 
increasingly more frequently administered in Germany 
and the Netherlands (Loh et al. 2012, van Waarde et al. 
2009). 
In the first decade of the 21st century the decline has 
continued at the DPPSU (Figure 1), although not to a 
statistically significant degree (p=0.08). Anecdotal 
evidence suggests that similar tendency of ECT use 
have been observed in other Hungarian centres. This 
situation could have several explanations. A major 
restructuring of the Hungarian health system took place 
in 2007, resulting in the closure of the National Institute 
of Psychiatry and Neurology, a key clinical and 
biological research centre in Budapest (Gazdag et al. 
2007), among other negative effects. One of the 
practical consequences was that the catchment area 
served by the DPPSU increased almost threefold, and so 
did the number of patients. The mean length of stay at 
the DPPSU decreased from 16 days in 1999 to 11.6 in 
2009 rendering ECT less available. Patients requiring 
longer treatment are now regularly transferred to other 
psychiatric facilities. The rapidly deteriorating financial 
situation of the health system could also have 
contributed to the decline of ECT. In Hungary, the 
Diagnosis Related Group (DRG) system finances in-
patient care. ECT does not have separate central funding 
in Hungary, and thus its use results in a significant 
financial burden on institutions. To date, efforts by 
mental health professionals to obtain special financing 
for the ECT have proven unsuccessful. A further 
possible reason for the decline of ECT practice could be 
that like all Hungarian psychiatric facilities, the DPPSU 
does not have its own anaesthesiologist, and securing an 
external collaborator can be difficult. There is also a 
lack of well-trained ECT nurses, partly because there is 
no ECT nurse training in Hungary. Finally, 
undergraduate medical education and residency training 
hardly cover ECT and regular refresher courses on the 
topic are also lacking.  
The majority of patients who received ECT 
treatment in Hungary during 2002 were diagnosed with 
schizophrenia (Gazdag et al. 2004a). Schizophrenia was 
also the most common indication in the DPPSU (Table 
2). This finding is difficult to explain or justify, as 
similar to international guidelines (Royal College of 
Psychiatrists 2004, American Psychiatric Association 
2001), the Hungarian ECT protocol (Hungarian College 
of Psychiatrists 2005) recommends ECT mainly for 
affective disorders. An earlier study (Gazdag et al. 
2009b) found that the majority of Hungarian 
psychiatrists still regard ECT as a last resort for patients 
resistant to any other therapeutic interventions, and 
prescribe it equally frequently for treatment-resistant 
cases of depression and schizophrenia (Gazdag et al. 
2004b). Because of the recent economical downturn and 
ECT’s lingering stigma (Takács et al. 2012), it is nearly 
impossible to obtain grants for research in this area in 
Hungary.  
The results of this survey suggest that for patients 
with affective disorders ECT is less frequently 
considered. The percentage of female patients receiving 
ECT in the sample significantly exceeded that of the 
male patients. Considering that the majority of the 
patients were suffering from schizophrenia, this 
deviance from the expected – nearly equal – sex-
distribution requires further exploration. It is also worth 
mentioning that the mean number of treatment sessions 
was much lower than recommended in Hungarian and 
international guidelines and, even more significantly, it 
was nearly the same across diagnostic groups. We 
hypothesize that the relatively small number of 
treatment sessions could be explained by misdiagnosing 
affective disorders for schizophrenia, as the former 
usually need fewer ECT sessions. At the same time, 
short courses could have disadvantaged patients with 
schizophrenia because ECT may have been stopped 
before significant improvement occurred. Changes in 
the composition of the medical staff could, in part, 
account for the annual variations in the number of ECT 
treatment sessions; it appears that the new generation of 
psychiatrists has poor knowledge of and less faith in 
ECT. 
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During the study period, ECT was also administered 
for rare indications. It has proved to be effective in the 
treatment of mood and psychotic symptoms associated 
with epilepsy (Farkas et al. 2002). Treating patients with 
epilepsy-related psychiatric disorders is one of the 
profiles of the DPPSU as a tertiary referral center. The 
treatment of psychotic symptoms in epilepsy poses a 
challenge, but the use of ECT is a feasible, though 
rarely considered, option (Micallef-Trigona & Spiteri 
2012).  
The main limitation of this survey is its retrospective 
nature. The clinical diagnoses were not confirmed by 
structured interviews or other specific diagnostic tools. 
EEG and EMG recordings were available only about 
60% of the sessions, and the seizure lengths were 
judged only by the cuff method in the rest of the cases. 
The relatively low percent of adverse effects could be 
because the majority of the patients treated with ECT 
were diagnosed with schizophrenia and certain side 
effects (e.g. cognitive impairment, confusion and/or 
disorientation) were often difficult to distinguish from 
the symptoms of psychosis or they might have not been 
documented accurately constituting another limitation 
of the survey. Finally, the reasons for terminating the 
course of ECT were not documented in the medical 
notes. 
 
CONCLUSION  
Despite its limitations, this study demonstrates the 
continuous decline in the annual number of ECT in 
Hungary’s leading ECT centre.  
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